Dermatology and Pregnancy

The document from May 30, 2017, outlines the skin changes and dermatological conditions that can occur during pregnancy, as well as their management. Physiological changes like hyperpigmentation and striae affect up to 90% of pregnant women, while pathological changes can include the exacerbation or improvement of preexisting skin conditions. Postpartum hair loss, or telogen effluvium, is common, with most patients recovering within a year. The document also details pregnancy-specific dermatoses, such as gestational pemphigoid with an incidence ranging from 1:7000 to 1:50,000 pregnancies, and other conditions like PUPPP, intrahepatic cholestasis, and atopic eruption of pregnancy, each with specific clinical presentations and treatments. Treatment options during pregnancy are limited due to fetal safety concerns, with recommendations including the cautious use of corticosteroids, antihistamines, and Ultraviolet B irradiation, while avoiding potent corticosteroids and maintaining low doses of systemic corticosteroids during the first trimester to prevent teratogenic effects.